Results 51 to 60 of about 21,523 (174)

Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Obesity is an increasingly prevalent, chronic, heterogeneous disease, associated with a variety of obesity‐related complications (ORCs). This systematic literature review assessed US healthcare resource utilisation (HCRU) and costs (direct and indirect) for people living with obesity (PwO) or overweight and ORCs.
Jaime P. Almandoz, Jamy D. Ard, Chellse Gazda, Shenelle Edwards‐Hampton   +3 more
wiley   +1 more source

Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels

Haemophilia, EarlyView.
ABSTRACT Introduction Valoctocogene roxaparvovec, an adeno‐associated virus (AAV)‐based gene therapy, enables endogenous factor VIII (FVIII) expression in patients with severe hemophilia A without the need for regular FVIII infusions. Long‐term follow‐up assesses durability, safety, and immune‐related challenges following gene therapy.
Kerstin Herbst, Behnaz Pezeshkpoor, Claudia Klein, Thilo Albert, Philipp Lutz, Christian Strassburg, Ulrich Spengler, Georg Goldmann, Johannes Oldenburg   +8 more
wiley   +1 more source

Safety and Efficacy of the VASCADE MVP® XL Venous Vascular Closure System for Management of Femoral Venotomy Following Catheter‐Based Interventions Utilizing 16‐17F OD Sheaths: The AMBULATE EXPAND Trial

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background With catheter‐based interventions increasingly requiring large‐bore venous access, reliable closure methods for 16‐17F sheaths are essential. Current manual compression techniques can prolong recovery, delay ambulation and discharge candidacy, and cause patient discomfort.
Hugh Thomas McElderry, Amin Al‐Ahmad, David De Lurgio, T. Jared Bunch, Zayd A. Eldadah, Maheer Gandhavadi, Bruce Hook, Joseph Banno, Suneet Mittal   +8 more
wiley   +1 more source

Effective Apixaban removal using hemoadsorption during emergent open-heart surgery: a case report and narrative literature review

Journal of Cardiothoracic Surgery
Background The management of hemostasis in patients medicated with apixaban (Eliquis) undergoing emergency cardiac surgery is exceedingly difficult. The body’s natural elimination pathways for apixaban prove ineffective in emergency situations, and the ...
Vitor Mendes, Jaid Mamode, Jalal Jolou, Mourad Malki, Christoph Ellenberger, Mustafa Cikirikcioglu, Christoph Huber   +6 more
doaj   +1 more source

Manejo del paciente anticoagulado con Acenocumarol en enfermería. Revisión Bibliográfica [PDF]

, 2019
Introducción. Las enfermedades cardiovasculares tienen una alta mortalidad a nivel mundial, además el envejecimiento de la población y el aumento de los factores de riesgo agravan esta situación.
Muñoz Biurrun, Laura
core  

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel, Sabrina Bänsch, Laura Adam, Nathan Fekade, Alessandra Rünger, Tim Zell, Daniel J. Smit, Julian Kött, Isabel Heidrich, Michael Weichenthal, Selma Ugurel, Ulrike Leiter, Peter Mohr, Alexandra Geusau, Stephan Grabbe, Markus V. Heppt, Ralf Gutzmer, Jochen Utikal, Jan‐Christoph Simon, Sebastian Haferkamp, Laura Susok, Bastian Schilling, Edgar Dippel, Imke von Wasielewski, Jessica C. Hassel, Carola Berking, Stefan W. Schneider, Christoffer Gebhardt   +27 more
wiley   +1 more source

Development of Pacemaker Lead Thrombosis in a Patient with Atrial Fibrillation during Apixaban Treatment

Journal of Tehran University Heart Center, 2019
Apixaban was introduced in clinical use for nonvalvular atrial fibrillation as an alternative to warfarin. There is a dearth of information regarding apixaban use in patients suffering from atrial fibrillation with intracardiac foreign bodies such as ...
Adem Adar, Orhan Önalan, Fahri Cakan
doaj   +1 more source

Practical issues with the use of rivaroxaban [PDF]

, 2013
El rivaroxabán es un inhibidor oral altamente selectivo del factor Xa. Actualmente, el uso de rivaroxabán está aprobado para la prevención del tromboembolismo venoso en adultos a los que se va a realizar un reemplazo electivo tanto de rodilla como de ...
Roldán, Vanessa, Suárez Fernández, Carmen, Vivancos, José   +2 more
core   +1 more source

Manejo práctico de los nuevos anticoagulantes orales en fibrilación auricular no valvular [PDF]

, 2019
Introduction. Atrial fibrillation is the most common arrhythmia in clinical practice. Itsincidence has been on the rise, reaching 8 % among those patients over the age of 80,with a significant impact on morbimortality related to cerebrovascular ...
Ardila-Acuña, Laura Yesenia, Laguado, Marlon, Mayorga-Quintero, Jairo Alberto, Rangel-Vera, Jully Andrea   +3 more
core   +2 more sources

Tratamiento con acenocumarol: estudio de la relación entre el grado de conocimientos acerca del fármaco, el cumplimiento del tratamiento y la estabilidad de los controles INR en intervalo terapéutico [PDF]

, 2013
[Resumen] Antecedentes: - El acenocumarol es el anticoagulante oral (ACO) de uso generalizado en nuestro medio. En estos pacientes resulta imprescindible el control analítico periódico de la coagulación (INR).
Martínez Rodríguez, Generosa
core